期刊文献+

硒对桥本甲状腺炎患者TPOAb及TGAb水平的影响 被引量:13

The Effect of Selenium on Thyroid Peroxidase Antibody and Thyroglobulin Antibody in Hashimoto Thyroiditis
下载PDF
导出
摘要 目的:观察硒对桥本甲状腺炎(HT)患者甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)的影响。方法:选取TPOAb在100~600IU/ml之间,TGAb在200IU/ml到2000IU/ml之间的HT患者66例,随机分为硒治疗组与对照组,硒治疗组(n=46)服硒酵母片(100I.Lg,2次,d)和左甲状腺素钠片(维持TSH至O.27~4.2μIU/m1)治疗;对照组(n=20)服左甲状腺素钠片(维持TSH至0.27—4.2μIU/m1)治疗,比较两组治疗3个月后TPOAb及TGAb水平的变化。结果:治疗3个月后两组TGAb水平与治疗前相比,差异无统计学意义(P〉0.05)。治疗3个月后,两组TPOAb水平明显降低,但降低值差异无统计学意义(P〈0.05)。结论:硒对桥本甲状腺炎患者轻度增高的TPOAb及TGAb水平无明显影响。 Objective: To observe the effect of selenium on thyroid peroxidase antibody ( TPOAb ) and thyroglobulin antibody ( TGAb ) in patients with Hashimoto thyroiditis ( HT ) .Method: 66 patients with HT whose TPOAb levels were between 100 IU/ml and 600 IU/ml, TGAb levels were between 200 and 2000 IU/ml were randomized into selenium treatment group and control group.The selenium treatment group ( n=46 ) received selenium yeast 200 μg per day , plus L-thyroxine to maintain TSH levels between 0.27-4.2μIU/ml ; the control group received L-thyroxine to maintain TSH levels between 0.27-4.2 μIU/ml.After 3 months compared the changes of TPOAb and TGAb levels in the two groups.Result: There were no significant changes of TGAb levels after 3 months of treatment compared with before treatment in the two groups ( P〉0.05 ) .There were significant decrease of TPOAb levels after 3 months in the two groups, but the reduction had no significant difference between the two groups.Conclusion: Selenium has no significant effect on slightly increased TPOAb and TGAb levels in HT.
出处 《中国医学创新》 CAS 2013年第14期13-14,共2页 Medical Innovation of China
关键词 桥本甲状腺炎 甲状腺过氧化物酶抗体 甲状腺球蛋白抗体 Selenium Hashimoto thyroiditi Peroxidase antibody Thyroglobulin antibody
  • 相关文献

参考文献8

  • 1Chistiakov DA. Immunogenetics of Hashimoto, s thyroiditis[J] .J Autoimmune Dis, 2005, 2 ( 1 ) : 1.
  • 2Hawkes WC, KeIIey DS, Taylor PC. The effects of dietary selenium on the immune system in healthy men[J]. Biol Trace Elem Res, 2001, 81 (3) : 189 -213.
  • 3Geoffreyy JB, John RA.Selenium and endocrine systems[J].J Endocrinol, 2005, 184 ( 3 ) : 455-465.
  • 4刘莉,平智广,朱本章.自身免疫性甲状腺病患者血清硒水平[J].中华内分泌代谢杂志,2005,21(6):537-538. 被引量:24
  • 5Leonidas HD, Emilla M, Demetrios AK.Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis[J].Eur Endoerinol, 2003, 148 ( 61 ) : 389-393.
  • 6Roland G, Barham C H, Gasnier J, et al. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidese antibodies coneentrations[J].J Clin Endoerinol Metab, 2002, 87 ( 7 ): 1687-1691.
  • 7Anastasilakis A D, Toulis K A, Nisianakis P, et al. Selenomethionine treatment in patients with autoimmune thyroiditis: a prospective, quasi-randomised trial[J]. Int J Clin Praet, 2012, 66 ( 4 ) : 378- 383.
  • 8Omer Turker, Kamil Kumanlioglu. Inane Karapolat and Ismail Dogan[J]. Journal of Endocrinology, 2006, 190 ( 45 ) : 151-156.

二级参考文献5

  • 1Kucharzewski M, Braziewicz J, Majewska U, et al. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res, 2002,88:25-30.
  • 2Ghose A, Fleming J, Harrison PR. Selenium and signal transduction: roads to cell death and anti-tumour activity. Biofactors, 2001,14: 127-133.
  • 3Gartner R, Gasnier BC. Selenium in the treatment of autoimmune thyroiditis. Biofactors, 2003,19 : 165-170.
  • 4刘莉,朱本章.微量元素硒与甲状腺[J].国外医学(医学地理分册),2003,24(3):122-124. 被引量:3
  • 5刘莉,朱本章.硒缺乏与甲状腺疾病[J].国外医学(内分泌学分册),2003,23(6):386-388. 被引量:9

共引文献23

同被引文献179

引证文献13

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部